Following on the observation that pharmacological inhibition of STING reduced IL-6 production upon topoisomerase 1 inhibition in mouse TC-1 cancer cells, we decided to broadly interrogate the role of STING signaling in the IL-6 response to acute DNA damage in human cancer cells. This evidence concerns the gene STING1 and cancer.